Log in
Enquire now
Glycomine

Glycomine

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
CEO
‌
Steven Axon
Crunchbase URL
crunchbase.com/organiz...lycomine
CTO
‌
Geoffrey Hird
Email Address
Founder
‌
Steven Axon
Industry
Pharmaceutical industry
Pharmaceutical industry
Biotechnology
Biotechnology
Health technology
Health technology
Investors
Novo Holdings
Novo Holdings
CTI Life Sciences Fund
CTI Life Sciences Fund
Asahi Kasei Pharma Venture Capital
Asahi Kasei Pharma Venture Capital
‌
Remiges Ventures
‌
Remiges Ventures
‌
Abrdn
Abingworth
Abingworth
Sanderling Ventures
Sanderling Ventures
RiverVest Venture Partners
RiverVest Venture Partners
Chiesi Ventures
Chiesi Ventures
•••
Latest Funding Round Date
April 16, 2025
Latest Funding Round Amount (USD)
115,000,000
Latest Funding Type
Series C
Series C
LinkedIn URL
@company/glycomine-inc-
Location
San Francisco, California, United
San Francisco, California, United
Number of Employees (Ranges)
1 – 10
Phone Number
Total Funding Amount (USD)
115,000,000
Twitter URL
@GlycomineBio
Official Website
glycomine.com

Find more companies like Glycomine

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.